S&P/ASX 200 gains 0.42% led by gold miners and property stocks

S&P/ASX 200 (INDEXASX:XJO) gained 0.42% to 7026.7 points by 1 pm with gold miners Northern Star (ASX:NST) and Westgold Resources (ASX:WGX) gaining more than 5% each. While the index is still down slightly this week, it is up 3.4% in April for its strongest monthly gain this year. The A-REIT sector gained 1.75% thanks to solid gains for Scentre (ASX:SCG) and Stockland (ASX:SGP). Online marketplace Redbubble (ASX:RBL) slumped 15% after its trading update. Top gainers Today’s top gainers on the ASX include Perpetual Resources Ltd (ASX:PEC) (+12.50%), Triangle Energy (Global) Ltd (ASX:TEG) (+16.00%), Alta Zinc Ltd (ASX:AZI) (+16.67%), Arrow Minerals Ltd (ASX:AMD) (+14.29%), Astro Resources N.L. (ASX:ARO) (+33.33%) and Golden Rim Resources Ltd. (ASX:GMR) (+20.00%). Proactive news headlines: MGC Pharmaceuticals to acquire worldwide clinical and medical research company MediCaNL MGC Pharmaceuticals Ltd (ASX:MXC) (LON:MXC) (OTCMKTS:MGCLF) (FRA:H5O) is acquiring MediCaNL Inc, an Israeli company providing specialist services worldwide to the pharmaceutical sector for the development of new medicines. archTIS lands key customer wins in Europe, Middle East and Africa market archTIS Ltd (ASX:AR9) has launched into the Europe, Middle East and Africa (EMEA) market with several new customer wins that validate its portfolio of data security products. Chalice Mining’s Julimar discovery continues to grow as drilling expands high-grade zones Chalice Mining Ltd (ASX:CHN) (OTCQB:CGMLF) continues to expand the footprint of its Julimar PGE-nickel-copper discovery near Perth, Western Australia, with strong new results from ongoing exploration seeing shares increase again this morning. Chimeric Therapeutics progresses to second dosing level with first patient cohort in CLTX CAR T Phase 1 trial Chimeric Therapeutics Limited (ASX:CHM) has confirmed that all patients dosed in the first patient cohort in City of Hope’s phase 1 CLTX CAR T cell clinical trial have advanced beyond the 28-day follow-up period without experiencing dose-limiting toxicities. Australian Potash awards key production bore-field drilling contract for LSOP Australian Potash Ltd (ASX:APC) has awarded the production bore-field drilling contract for the development of Lake Wells Sulphate of Potash Project (LSOP) near Laverton in Western Australia. Lithium Australia's Soluna Australia JV gains CEC approval for 10K Pack HV battery systems for residential applications Lithium Australia NL’s (ASX:LIT) (OTCMKTS:LMMFF) (FRA:3MW) incorporated joint venture, Soluna Australia Pty Ltd has received Clean Energy Council (CEC) approval for the 10K Pack HV pre-assembled battery systems for residential applications.  Zelira Therapeutics well-placed to build on considerable March quarter momentum Zelira Therapeutics Ltd (ASX:ZLD) (OTCQB:ZLDAF) (FRA:G1G) is well placed to build on the considerable momentum generated during the March quarter by launching new products and expanding into new geographies, according to managing director Dr Oludare Odumosu.